{"id":981,"date":"2024-02-28T15:40:29","date_gmt":"2024-02-28T14:40:29","guid":{"rendered":"https:\/\/www.utopiasis.it\/?page_id=981"},"modified":"2024-03-07T22:21:49","modified_gmt":"2024-03-07T21:21:49","slug":"marina-golinelli-board-member","status":"publish","type":"page","link":"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/","title":{"rendered":"Marina Golinelli"},"content":{"rendered":"\n[et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” background_image=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/experiment-biotechnology-with-chemistry-science-scaled.jpg” background_enable_mask_style=”on” background_mask_style=”caret” background_mask_color=”gcid-237e273c-f56a-4eda-aaac-e80fb41a0548″ custom_margin=”85px||||false|false” global_colors_info=”{%22gcid-237e273c-f56a-4eda-aaac-e80fb41a0548%22:%91%22background_mask_color%22%93}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”Marina Golinelli” _builder_version=”4.24.2″ _module_preset=”default” title_text_color=”#FFFFFF” title_font_size=”40px” custom_margin=”||0px||false|false” global_colors_info=”{}”][\/et_pb_heading][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_row column_structure=”1_4,3_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/Marina-Golinelli_44_b-scaled.jpg” title_text=”Marina Golinelli_44_b” _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][et_pb_column type=”3_4″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#000000″ text_font_size=”17px” text_line_height=”1.8em” text_orientation=”justified” hover_enabled=”0″ locked=”off” global_colors_info=”{}” sticky_enabled=”0″]

Marina Golinelli, a board member of Utopia SIS<\/a> since March 2021, is a shareholder and member of the Board of Directors of Alfasigma, one of the leading pharmaceutical companies with Italian capital, with an international presence in over 100 countries.<\/p>\n

Since 2022, she has also joined the Board of Directors of Fondazione Golinelli<\/a>, a private philanthropic organization established by Marino Golinelli that focuses on education, training, research, innovation, and culture to promote the intellectual and ethical growth of young people and society.<\/p>\n

Passionate about contemporary art, Marina graduated in Economics for Art, Culture, and Communication from Bocconi University and then deepened her interest in finance with a Master’s in Administration, Corporate Finance, and Control, gaining diverse work experiences in Corporate Finance, both in strategic consulting firms and multinational industrial companies.<\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]\n","protected":false},"excerpt":{"rendered":"

Marina Golinelli, a board member of Utopia SIS since March 2021, is a shareholder and member of the Board of Directors of Alfasigma, one of the leading pharmaceutical companies with Italian capital, with an international presence in over 100 countries. Since 2022, she has also joined the Board of Directors of Fondazione Golinelli, a private […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"[et_pb_section fb_built=\"1\" _builder_version=\"4.24.2\" _module_preset=\"default\" background_image=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/experiment-biotechnology-with-chemistry-science-scaled.jpg\" background_enable_mask_style=\"on\" background_mask_style=\"caret\" background_mask_color=\"gcid-237e273c-f56a-4eda-aaac-e80fb41a0548\" custom_margin=\"85px||||false|false\" global_colors_info=\"{%22gcid-237e273c-f56a-4eda-aaac-e80fb41a0548%22:%91%22background_mask_color%22%93}\"][et_pb_row column_structure=\"1_2,1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_column type=\"1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_heading title=\"Marina Golinelli\" _builder_version=\"4.24.2\" _module_preset=\"default\" title_text_color=\"#FFFFFF\" title_font_size=\"40px\" custom_margin=\"||0px||false|false\" global_colors_info=\"{}\"][\/et_pb_heading][\/et_pb_column][et_pb_column type=\"1_2\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\"1\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_row column_structure=\"1_4,3_4\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_column type=\"1_4\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_image src=\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/Marina-Golinelli_44_b-scaled.jpg\" title_text=\"Marina Golinelli_44_b\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][\/et_pb_image][\/et_pb_column][et_pb_column type=\"3_4\" _builder_version=\"4.24.2\" _module_preset=\"default\" global_colors_info=\"{}\"][et_pb_text _builder_version=\"4.24.2\" _module_preset=\"default\" text_text_color=\"#000000\" text_font_size=\"17px\" text_line_height=\"1.8em\" text_orientation=\"justified\" locked=\"off\" global_colors_info=\"{}\"]\n\nMarina Golinelli, consigliere di Utopia SIS<\/a> dal marzo 2021, \u00e8 azionista e membro del CdA dell'azienda di Alfasigma, una delle principali industrie farmaceutiche a capitale italiano, con una presenza internazionale in oltre 100 Paesi.\n\nDal 2022 \u00e8 entrata a far parte anche del CdA della Fondazione Golinelli<\/a>, l\u2019ente filantropico privato nato dalla volont\u00e0 di Marino Golinelli che si occupa di educazione, formazione, ricerca, innovazione e cultura per favorire la crescita intellettuale ed etica dei giovani e della societ\u00e0.\n\nDa sempre appassionata di arte contemporanea, Marina si \u00e8 laureata in Economia per l\u2019Arte, la Cultura e la Comunicazione all'Universit\u00e0 Bocconi e ha poi approfondito il suo interesse per la finanza con un Master in Amministrazione, Finanza Aziendale e Controllo e con diverse esperienze lavorative nel Corporate Finance, sia in societ\u00e0 di consulenza strategica sia in societ\u00e0 industriali multinazionali.\n\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]","_et_gb_content_width":"","footnotes":""},"class_list":["post-981","page","type-page","status-publish","hentry"],"yoast_head":"\nMarina Golinelli - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE<\/title>\n<meta name=\"description\" content=\"Marina Golinelli, a board member of Utopia SIS since March 2021, is a shareholder and member of the Board of Directors of Alfasigma, one of the leading pharmaceutical companies with Italian capital, with an international presence in over 100 countries.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marina Golinelli - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE\" \/>\n<meta property=\"og:description\" content=\"Marina Golinelli, a board member of Utopia SIS since March 2021, is a shareholder and member of the Board of Directors of Alfasigma, one of the leading pharmaceutical companies with Italian capital, with an international presence in over 100 countries.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/\" \/>\n<meta property=\"og:site_name\" content=\"UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-07T21:21:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/\",\"url\":\"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/\",\"name\":\"Marina Golinelli - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE\",\"isPartOf\":{\"@id\":\"https:\/\/utopia.p82.it\/#website\"},\"datePublished\":\"2024-02-28T14:40:29+00:00\",\"dateModified\":\"2024-03-07T21:21:49+00:00\",\"description\":\"Marina Golinelli, a board member of Utopia SIS since March 2021, is a shareholder and member of the Board of Directors of Alfasigma, one of the leading pharmaceutical companies with Italian capital, with an international presence in over 100 countries.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.utopiasis.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Marina Golinelli\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/utopia.p82.it\/#website\",\"url\":\"https:\/\/utopia.p82.it\/\",\"name\":\"utopia sis\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/utopia.p82.it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/utopia.p82.it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/utopia.p82.it\/#organization\",\"name\":\"utopia sis\",\"url\":\"https:\/\/utopia.p82.it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/utopia.p82.it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/logo-utopia-v-buona.jpg\",\"contentUrl\":\"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/logo-utopia-v-buona.jpg\",\"width\":569,\"height\":191,\"caption\":\"utopia sis\"},\"image\":{\"@id\":\"https:\/\/utopia.p82.it\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marina Golinelli - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE","description":"Marina Golinelli, a board member of Utopia SIS since March 2021, is a shareholder and member of the Board of Directors of Alfasigma, one of the leading pharmaceutical companies with Italian capital, with an international presence in over 100 countries.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/","og_locale":"en_US","og_type":"article","og_title":"Marina Golinelli - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE","og_description":"Marina Golinelli, a board member of Utopia SIS since March 2021, is a shareholder and member of the Board of Directors of Alfasigma, one of the leading pharmaceutical companies with Italian capital, with an international presence in over 100 countries.","og_url":"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/","og_site_name":"UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE","article_modified_time":"2024-03-07T21:21:49+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/","url":"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/","name":"Marina Golinelli - UTOPIA SOCIETA' DI INVESTIMENTO SEMPLICE","isPartOf":{"@id":"https:\/\/utopia.p82.it\/#website"},"datePublished":"2024-02-28T14:40:29+00:00","dateModified":"2024-03-07T21:21:49+00:00","description":"Marina Golinelli, a board member of Utopia SIS since March 2021, is a shareholder and member of the Board of Directors of Alfasigma, one of the leading pharmaceutical companies with Italian capital, with an international presence in over 100 countries.","breadcrumb":{"@id":"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.utopiasis.it\/en\/marina-golinelli-board-member\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.utopiasis.it\/en\/"},{"@type":"ListItem","position":2,"name":"Marina Golinelli"}]},{"@type":"WebSite","@id":"https:\/\/utopia.p82.it\/#website","url":"https:\/\/utopia.p82.it\/","name":"utopia sis","description":"","publisher":{"@id":"https:\/\/utopia.p82.it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/utopia.p82.it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/utopia.p82.it\/#organization","name":"utopia sis","url":"https:\/\/utopia.p82.it\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/utopia.p82.it\/#\/schema\/logo\/image\/","url":"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/logo-utopia-v-buona.jpg","contentUrl":"https:\/\/www.utopiasis.it\/wp-content\/uploads\/2024\/02\/logo-utopia-v-buona.jpg","width":569,"height":191,"caption":"utopia sis"},"image":{"@id":"https:\/\/utopia.p82.it\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/pages\/981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/comments?post=981"}],"version-history":[{"count":5,"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/pages\/981\/revisions"}],"predecessor-version":[{"id":986,"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/pages\/981\/revisions\/986"}],"wp:attachment":[{"href":"https:\/\/www.utopiasis.it\/en\/wp-json\/wp\/v2\/media?parent=981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}